Page last updated: 2024-08-23

idarubicin and Syndrome

idarubicin has been researched along with Syndrome in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's6 (54.55)29.6817
2010's4 (36.36)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caviedes, MP; Galimberti, RL; Maqueda, MG; Piñero, MC; Riganti, J; Torre, AC; Volonteri, VI1
Chelazzi, C; De Gaudio, AR; Ronco, C; Sharma, A; Villa, G; Zaragoza, JJ1
Avvisati, G; Breccia, M; Cannella, L; Carmosino, I; Cimino, G; De Propris, MS; Diverio, D; Guarini, A; Latagliata, R; Lo-Coco, F; Mandelli, F; Petti, MC1
Fenaux, P; Ghédira, H; Gouider, E; Jeddi, R; Meddeb, B; Mnif, S1
Avvisati, G; Bagnardi, V; Breccia, M; Cimino, G; Disalvatore, D; Foà, R; Latagliata, R; Lo-Coco, F; Loglisci, G; Mazzarella, L; Minotti, C; Pelicci, PG; Petti, MC; Testi, AM1
Go, RS; Johnston, KL1
Gupta, V; Keating, A; Tabak, D1
Abruzzo, LV; Bobadilla, D; Cortes, J; Gibbons, DL; Kantarjian, H; Quintás-Cardama, A; Slovak, ML1
Amutio, E; Bergua, JM; Brunet, S; de la Serna, J; Debén, G; Díaz-Mediavilla, J; Esteve, J; González, JD; González, M; León, A; Lowenberg, B; Milone, G; Montesinos, P; Negri, S; Parody, R; Rayón, C; Rivas, C; Sanz, MA; Tormo, M; Vellenga, E1
Avvisati, G; Barbui, T; Bernasconi, C; Biondi, A; Broccia, G; Cerri, R; Diverio, D; Falda, M; Fioritoni, G; Jehn, U; Leoni, F; Liso, V; Lo Coco, F; Luciano, A; Mandelli, F; Muus, P; Pelicci, PG; Petti, MC; Rodeghiero, F; Saglio, G; Vegna, ML; Visani, G; Willemze, R1
Spedini, P1

Reviews

2 review(s) available for idarubicin and Syndrome

ArticleYear
Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.
    European journal of haematology, 2003, Volume: 70, Issue:4

    Topics: Abnormalities, Multiple; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Cytokines; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Menorrhagia; Neoplasm Proteins; Platelet Count; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Recurrence; Remission Induction; Risk; Syndrome; Thrombocytopenia

2003
Acute promyelocytic leukemia: a case-based review.
    Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Case Management; Evidence-Based Medicine; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Neoplasm Proteins; Oncogene Proteins, Fusion; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Syndrome; Tretinoin

2003

Trials

3 trial(s) available for idarubicin and Syndrome

ArticleYear
High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia.
    Leukemia research, 2010, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Child, Preschool; Disease Progression; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Prognosis; Survival Analysis; Syndrome; Tretinoin; Young Adult

2010
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
    Blood, 2008, Apr-01, Volume: 111, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Child, Preschool; Creatinine; Disease-Free Survival; Female; Hemorrhage; Humans; Idarubicin; Infections; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Risk Factors; Sex Factors; Survival Rate; Syndrome; Treatment Failure; Tretinoin

2008
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pe
    Blood, 1997, Aug-01, Volume: 90, Issue:3

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Child; Child, Preschool; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Disease-Free Survival; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prospective Studies; Remission Induction; Syndrome; Translocation, Genetic; Treatment Outcome; Tretinoin

1997

Other Studies

6 other study(ies) available for idarubicin and Syndrome

ArticleYear
Lingual ulceration associated with retinoic acid syndrome during treatment of acute promyelocytic leukemia.
    International journal of dermatology, 2014, Volume: 53, Issue:7

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Febrile Neutropenia; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Oral Ulcer; Syndrome; Tongue Diseases; Tretinoin

2014
High cutoff membrane to reduce systemic inflammation due to differentiation syndrome: a case report.
    Blood purification, 2014, Volume: 38, Issue:3-4

    Topics: Acute Kidney Injury; Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Calcium Citrate; Capillary Leak Syndrome; Cell Differentiation; Disseminated Intravascular Coagulation; Fatal Outcome; Hemofiltration; Humans; Idarubicin; Immunomodulation; Inflammation; Inflammation Mediators; Leukemia, Promyelocytic, Acute; Male; Membranes, Artificial; Molecular Weight; Permeability; Prednisolone; Respiratory Insufficiency; Serum Albumin; Syndrome; Tretinoin

2014
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
    Haematologica, 2008, Volume: 93, Issue:12

    Topics: Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Syndrome; Treatment Outcome; Tretinoin

2008
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.
    Blood, 2012, Jan-05, Volume: 119, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity; Overweight; Prognosis; Risk Factors; Survival Rate; Syndrome; Tretinoin; Young Adult

2012
Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia.
    Leukemia, 2008, Volume: 22, Issue:4

    Topics: Chromosomes, Human, Pair 3; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Philadelphia Chromosome; Syndrome; Time Factors

2008
Retinoic acid syndrome: a case of massive lung consolidation.
    Haematologica, 2002, Volume: 87, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fever; Humans; Hypotension; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocytosis; Lung; Male; Respiratory Distress Syndrome; Syndrome; Tretinoin

2002